Literature DB >> 27862091

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

O Simmons1, D T Fetzer2, T Yokoo2, J A Marrero1, A Yopp3, Y Kono4, N D Parikh5, T Browning2, A G Singal1,6,7.   

Abstract

BACKGROUND: Abdominal ultrasound fails to detect over one-fourth of hepatocellular carcinoma (HCC) at an early stage in patients with cirrhosis. Identifying patients in whom ultrasound is of inadequate quality can inform interventions to improve surveillance effectiveness. AIM: To evaluate and identify predictors of ultrasound quality in patients with cirrhosis.
METHODS: We performed a retrospective cohort study among patients who underwent ultrasound examination for a cirrhosis-related indication between April 2015 and October 2015. Three fellowship-trained abdominal radiologists collectively reviewed all ultrasound exams and categorised exam quality as definitely adequate, likely adequate, likely inadequate and definitely inadequate to exclude liver lesions. We performed multivariable logistic regression to determine characteristics associated with inadequate ultrasound quality.
RESULTS: Among 941 patients, 191 (20.3%) ultrasounds were inadequate for excluding HCC- 134 definitely inadequate and 57 likely inadequate. In multivariable analysis, inadequate quality was associated with male gender (OR 1.68, 95% CI 1.14-2.48), body mass index category (OR 1.67, 95% CI 1.45-1.93), Child-Pugh B or C cirrhosis (OR 1.93, 95% CI 1.32-2.81), alcohol-related cirrhosis (OR 2.11, 95% CI 1.33-3.37), NASH cirrhosis (OR 2.87, 95% CI 1.71-4.80), and in-patient status (OR 1.55, 95% CI 1.01-2.37). Ultrasounds were inadequate in over one-third of patients with Child-Pugh C cirrhosis, BMI >35, or NASH cirrhosis.
CONCLUSIONS: One in five ultrasounds in patients with cirrhosis are inadequate for exclusion of HCC, which can contribute to surveillance failure. Alternative surveillance modalities are needed in subgroups prone to inadequate ultrasounds including obese patients, those with Child Pugh B or C cirrhosis, and those with alcohol- or NASH-related cirrhosis.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27862091      PMCID: PMC7207219          DOI: 10.1111/apt.13841

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  22 in total

1.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

Review 2.  Epidemiology of viral hepatitis and hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

3.  Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands.

Authors:  Suzanne van Meer; Robert A de Man; Minneke J Coenraad; Dave Sprengers; Karin M J van Nieuwkerk; Heinz-Josef Klümpen; Peter L M Jansen; Jan N M IJzermans; Martijn G H van Oijen; Peter D Siersema; Karel J van Erpecum
Journal:  J Hepatol       Date:  2015-06-20       Impact factor: 25.083

4.  Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports.

Authors:  Raul N Uppot; Dushyant V Sahani; Peter F Hahn; Mannudeep K Kalra; Sanjay S Saini; Peter R Mueller
Journal:  Radiology       Date:  2006-06-26       Impact factor: 11.105

5.  The effectiveness of ultrasound surveillance for hepatocellular carcinoma in a Canadian centre and determinants of its success.

Authors:  Korosh Khalili; Ravi Menezes; Tae Kyoung Kim; Leyla Kochak Yazdi; Hyun-Jung Jang; Suraj Sharma; Jordan Feld; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jun-Jul

6.  Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.

Authors:  Paolo Del Poggio; Stefano Olmi; Francesca Ciccarese; Mariella Di Marco; Gian Ludovico Rapaccini; Luisa Benvegnù; Franco Borzio; Fabio Farinati; Marco Zoli; Edoardo Giovanni Giannini; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani
Journal:  Clin Gastroenterol Hepatol       Date:  2014-02-26       Impact factor: 11.382

7.  Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?

Authors:  Amit G Singal; Mahendra Nehra; Beverley Adams-Huet; Adam C Yopp; Jasmin A Tiro; Jorge A Marrero; Anna S Lok; William M Lee
Journal:  Am J Gastroenterol       Date:  2013-01-22       Impact factor: 10.864

8.  Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Karin L Andersson; Joshua A Salomon; Sue J Goldie; Raymond T Chung
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

9.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors:  Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

10.  Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma.

Authors:  Amit G Singal; Ashin Mukherjee; B Joseph Elmunzer; Peter D R Higgins; Anna S Lok; Ji Zhu; Jorge A Marrero; Akbar K Waljee
Journal:  Am J Gastroenterol       Date:  2013-10-29       Impact factor: 10.864

View more
  83 in total

1.  Should AFP (or any biomarkers) be used for HCC surveillance?

Authors:  Hager F Ahmed Mohammed; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2017-04-28

Review 2.  Optimal Modalities for HCC Surveillance in a High-Incidence Region.

Authors:  Young Chang; Jeong-Hoon Lee
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

Review 3.  Abbreviated Magnetic Resonance Imaging for HCC Surveillance.

Authors:  Naik Vietti Violi; Kathryn J Fowler; Claude B Sirlin; Bachir Taouli
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 4.  Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.

Authors:  Shreya Sengupta; Neehar D Parikh
Journal:  Hepat Oncol       Date:  2017-11-17

5.  Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

Authors:  Kristina Tzartzeva; Joseph Obi; Nicole E Rich; Neehar D Parikh; Jorge A Marrero; Adam Yopp; Akbar K Waljee; Amit G Singal
Journal:  Gastroenterology       Date:  2018-02-06       Impact factor: 22.682

Review 6.  AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.

Authors:  Rohit Loomba; Joseph K Lim; Heather Patton; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2020-01-30       Impact factor: 22.682

Review 7.  Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance.

Authors:  Nicole E Rich; Neehar D Parikh; Amit G Singal
Journal:  Semin Liver Dis       Date:  2017-12-22       Impact factor: 6.115

8.  Frequency and Outcomes of Abnormal Imaging in Patients With Cirrhosis Enrolled in a Hepatocellular Carcinoma Surveillance Program.

Authors:  Monica A Konerman; Aashesh Verma; Betty Zhao; Amit G Singal; Anna S Lok; Neehar D Parikh
Journal:  Liver Transpl       Date:  2019-03       Impact factor: 5.799

9.  CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data.

Authors:  Amit G Singal
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

10.  PRO: Hepatocellular Carcinoma Surveillance: A Useful Tool Against the Rising Tide of HCC.

Authors:  Neehar D Parikh
Journal:  Am J Gastroenterol       Date:  2017-10-03       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.